Cancer Letters
Volume 224, Issue 1 , Pages 23-30 , 16 June 2005

Equivocal impact of transplacental and lactational exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, on prostate and colon lesion development in F344 rats

Received 27 August 2004 ,Revised 26 October 2004 ,Accepted 28 October 2004.

References 

  1. Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390–395
  2. Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 2004;95:290–299
  3. Wakabayashi K, Ushiyama H, Takahashi M, Nukaya H, Kim SB, Hirose M, et al. Exposure to heterocyclic amines. Environ. Health Perspect. 1993;99:129–134
  4. Felton JS, Knize MG, Shen NH, Lewis PR, Andresen BD, Happe J, et al. The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 1986;7:1081–1086
  5. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 1991;12:1503–1506
  6. Hasegawa R, Sano M, Tamano S, Imaida K, Shirai T, Nagao M, et al. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) carcinogenicity in rats. Carcinogenesis. 1993;14:2553–2557
  7. Rao CV, Rivenson A, Zang E, Steele V, Kelloff G, Reddy BS. Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced lymphoma formation by oltiplaz. Cancer Res. 1996;56:3395–3398
  8. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res. 1997;57:195–198
  9. Ito N, Hasegawa R, Imaida K, Tamano S, Hagiwara A, Hirose M, et al. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat. Res. 1997;376:107–114
  10. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986;58:2363–2371
  11. Gerhardsson de Verdier M, Hagman U, Peters RK, Steineck G, Overvik E. Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int. J. Cancer. 1991;49:520–525
  12. Lyon JL, Mahoney AW. Fried foods and the risk of colon cancer. Am. J. Epidemiol. 1988;128:1000–1006
  13. Sinha R, Kulldorff M, Chow WH, Denobile J, Rothman N. Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 2001;10:559–562
  14. Sinha R, Kulldorff M, Swanson CA, Curtin J, Brownson RC, Alavanja MC. Dietary heterocyclic amines and the risk of lung cancer among Missouri women. Cancer Res. 2000;60:3753–3756
  15. Sinha R, Gustafson DR, Kulldorff M, Wen WQ, Cerhan JR, Zheng W. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J. Natl. Cancer Inst. 2000;92:1352–1354
  16. Bogen KT, Keating GA. US dietary exposures to heterocyclic amines. J. Expo. Anal. Environ. Epidemiol. 2001;11:155–168
  17. Ghoshal A, Snyderwine EG. Excretion of food-derived heterocyclic amine carcinogens into breast milk of lactating rats and formation of DNA adducts in the newborn. Carcinogenesis. 1993;14:2199–2203
  18. Davis CD, Ghoshal A, Schut HA, Snyderwine EG. Metabolism of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by lactating Fischer 344 rats and their nursing pups. J. Natl. Cancer Inst. 1994;86:1065–1070
  19. Brittebo EB, Karlsson AA, Skog KI, Jagerstad IM. Transfer of the food mutagen PhIP to foetuses and newborn mice following maternal exposure. Food Chem. Toxicol. 1994;32:717–726
  20. Hasegawa R, Kimura J, Yaono M, Takahashi S, Kato T, Futakuchi M, et al. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague–Dawley rats. Cancer Res. 1995;55:4333–4338
  21. DeBruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem. Res. Toxicol. 2001;14:1523–1528
  22. Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, Kadlubar FF. Carcinogen-DNA adducts in human breast epithelial cells. Environ. Mol. Mutagen. 2002;39:184–192
  23. Takahashi S, Tamano S, Hirose M, Kimoto N, Ikeda Y, Sakakibara M, et al. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. Cancer Res. 1998;58:4307–4313
  24. Ikeda Y, Takahashi S, Kimura J, Cho YM, Imaida K, Shirai S, et al. Anophthalmia in litters of female rats treated with the food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Toxicol. Pathol. 1999;27:628–631
  25. Hagiwara A, Boonyaphiphat P, Tanaka H, Kawabe M, Tamano S, Kaneko H, et al. Organ-dependent modifying effects of caffeine, and two naturally occurring antioxidants alpha-tocopherol and n-tritriacontane-16,18-dione, on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary and colonic carcinogenesis in female F344 rats. Jpn. J. Cancer Res. 1999;90:399–405
  26. Imaida K, Hagiwara A, Yada H, Masui T, Hasegawa R, Hirose M, et al. Dose-dependent induction of mammary carcinomas in female Sprague–Dawley rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 1996;87:1116–1120
  27. Fukushima S, Wanibuchi H, Morimura K, Iwai S, Nakae D, Kishida H, et al. Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Toxicol. Sci. 2004;80:109–114
  28. Stillwell WG, Kidd LCR, Wishnok JS, Tannenbaum SR, Sinha R. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: Relationship to cytochrome P4501A2 and N-acetyltransferase activity. Cancer Res. 1997;57:3457–3464
  29. Malfatti MA, Connors MS, Mauthe RJ, Felton JS. The capability of rat colon tissue slices to metabolize the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 1996;56:2550–2555
  30. Kaderlik KR, Minchin RF, Mulder GJ, Ilett KF, Daugaard-Jenson M, Teitel CH, et al. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis. 1994;15:1703–1709
  31. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 1995;16:39–52
  32. Byrne C, Sinha R, Platz EA, Giovannucci E, Colditz GA, Hunter DJ, et al. Predictors of dietary heterocyclic amine intake in three prospective cohorts. Cancer Epidemiol. Biomarkers Prev. 1998;7:523–529
  33. Keating GA, Bogen KT. Estimates of heterocyclic amine intake in the US population. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004;802:127–133
  34. Augustsson K, Skog K, Jagerstad M, Steineck G. Assessment of the human exposure to heterocyclic amines. Carcinogenesis. 1997;18:1931–1935
  35. Zimmerli B, Rhyn P, Zoller O, Schlatter J. Occurrence of heterocyclic amines in the Swiss diet: analytical method, exposure estimation and risk assessment. Food Addit. Contam. 2001;18:533–551
  36. Kobayashi M, Hanaoka T, Nishioka S, Kataoka H, Tsugane S. Estimation of dietary HCA intakes in a large-scale population-based prospective study in Japan. Mutat. Res. 2002;506/507:233–241
  37. Ushiyama H, Wakabayashi K, Hirose M, Itoh H, Sugimura T, Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis. 1991;12:1417–1422
  38. Peluso M, Castegnaro M, Malaveille C, Friesen M, Garren L, Hautefeuille A, et al. 32P-Postlabeling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis. 1991;12:713–717

PII: S0304-3835(04)00847-X

doi: 10.1016/j.canlet.2004.10.040

Cancer Letters
Volume 224, Issue 1 , Pages 23-30 , 16 June 2005

Article Tools

* Image Usage & Resolution